node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
C31H2.4 | pgal-1 | C31H2.4.1 | F21F3.1.1 | Putative protein C31H2.4. | Probable peptidyl-alpha-hydroxyglycine alpha-amidating lyase pgal-1; Probable lyase that catalyzes an essential reaction in C- terminal alpha-amidation of peptides. Mediates the dismutation of the unstable peptidyl(2-hydroxyglycine) intermediate to glyoxylate and the corresponding desglycine peptide amide. C-terminal amidation of peptides such as neuropeptides is essential for full biological activity (By similarity). | 0.662 |
cdc-14 | pgal-1 | C17G10.4h.1 | F21F3.1.1 | Tyrosine-protein phosphatase cdc-14; Protein phosphatase that negatively regulates the G1-to-S phase transition to inhibit the cell cycle and establish quiescence in cells of multiple lineages including vulval, hypodermal and intestinal. Promotes nuclear accumulation and activity of the cyclin-dependent kinase inhibitor cki-1 which leads to inhibition of G1 progression during vulval tissue development. Has been shown to not be required for cytokinesis. However, in the embryo, in a contrasting study, has been shown to act as a regulator of central spindle formation and cytokinesis, and [...] | Probable peptidyl-alpha-hydroxyglycine alpha-amidating lyase pgal-1; Probable lyase that catalyzes an essential reaction in C- terminal alpha-amidation of peptides. Mediates the dismutation of the unstable peptidyl(2-hydroxyglycine) intermediate to glyoxylate and the corresponding desglycine peptide amide. C-terminal amidation of peptides such as neuropeptides is essential for full biological activity (By similarity). | 0.660 |
cdc-14 | pgk-1 | C17G10.4h.1 | T03F1.3.1 | Tyrosine-protein phosphatase cdc-14; Protein phosphatase that negatively regulates the G1-to-S phase transition to inhibit the cell cycle and establish quiescence in cells of multiple lineages including vulval, hypodermal and intestinal. Promotes nuclear accumulation and activity of the cyclin-dependent kinase inhibitor cki-1 which leads to inhibition of G1 progression during vulval tissue development. Has been shown to not be required for cytokinesis. However, in the embryo, in a contrasting study, has been shown to act as a regulator of central spindle formation and cytokinesis, and [...] | Probable phosphoglycerate kinase; Belongs to the phosphoglycerate kinase family. | 0.450 |
flp-11 | flp-12 | K02G10.4a.1 | C05E11.8a.1 | FMRFamide-like neuropeptides 11; FMRFamides and FMRFamide-like peptides are neuropeptides. [ASGGMRNALVRF-amide]: Acts as a ligand for the npr-22 receptor in vitro; Belongs to the FARP (FMRFamide related peptide) family. | FMRFamide-like peptide 12. | 0.909 |
flp-11 | flp-19 | K02G10.4a.1 | M79.4.1 | FMRFamide-like neuropeptides 11; FMRFamides and FMRFamide-like peptides are neuropeptides. [ASGGMRNALVRF-amide]: Acts as a ligand for the npr-22 receptor in vitro; Belongs to the FARP (FMRFamide related peptide) family. | FMRFamide-like neuropeptides 19; FMRFamides and FMRFamide-like peptides are neuropeptides. WANQVRF-amide inhibits the activity of dissected pharyngeal myogenic muscle system; Belongs to the FARP (FMRFamide related peptide) family. | 0.855 |
flp-11 | flp-9 | K02G10.4a.1 | C36H8.3.1 | FMRFamide-like neuropeptides 11; FMRFamides and FMRFamide-like peptides are neuropeptides. [ASGGMRNALVRF-amide]: Acts as a ligand for the npr-22 receptor in vitro; Belongs to the FARP (FMRFamide related peptide) family. | FMRFamide-like neuropeptides 9; FMRFamides and FMRFamide-like peptides are neuropeptides. Belongs to the FARP (FMRFamide related peptide) family. | 0.889 |
flp-11 | pgal-1 | K02G10.4a.1 | F21F3.1.1 | FMRFamide-like neuropeptides 11; FMRFamides and FMRFamide-like peptides are neuropeptides. [ASGGMRNALVRF-amide]: Acts as a ligand for the npr-22 receptor in vitro; Belongs to the FARP (FMRFamide related peptide) family. | Probable peptidyl-alpha-hydroxyglycine alpha-amidating lyase pgal-1; Probable lyase that catalyzes an essential reaction in C- terminal alpha-amidation of peptides. Mediates the dismutation of the unstable peptidyl(2-hydroxyglycine) intermediate to glyoxylate and the corresponding desglycine peptide amide. C-terminal amidation of peptides such as neuropeptides is essential for full biological activity (By similarity). | 0.538 |
flp-11 | pghm-1 | K02G10.4a.1 | Y71G12B.4.1 | FMRFamide-like neuropeptides 11; FMRFamides and FMRFamide-like peptides are neuropeptides. [ASGGMRNALVRF-amide]: Acts as a ligand for the npr-22 receptor in vitro; Belongs to the FARP (FMRFamide related peptide) family. | Probable peptidylglycine alpha-hydroxylating monooxygenase 1; Monooxygenase that catalyzes an essential reaction in C- terminal alpha-amidation of peptides. Produces an unstable peptidyl(2- hydroxyglycine) intermediate. C-terminal amidation of peptides such as neuropeptides is essential for full biological activity. Belongs to the copper type II ascorbate-dependent monooxygenase family. | 0.540 |
flp-11 | sbt-1 | K02G10.4a.1 | T03D8.3.1 | FMRFamide-like neuropeptides 11; FMRFamides and FMRFamide-like peptides are neuropeptides. [ASGGMRNALVRF-amide]: Acts as a ligand for the npr-22 receptor in vitro; Belongs to the FARP (FMRFamide related peptide) family. | Seven B Two (Mammalian 7BT prohormone convertase chaperone) homolog. | 0.581 |
flp-11 | snet-1 | K02G10.4a.1 | C02F12.3.1 | FMRFamide-like neuropeptides 11; FMRFamides and FMRFamide-like peptides are neuropeptides. [ASGGMRNALVRF-amide]: Acts as a ligand for the npr-22 receptor in vitro; Belongs to the FARP (FMRFamide related peptide) family. | Protein snet-1; Negatively regulates chemotaxis and olfactory plasticity which is the change from positive chemotaxis to dispersal after prolonged exposure to an odorant. May be down-regulated in response to pheromone exposure, resulting in promotion of olfactory plasticity. | 0.592 |
flp-12 | flp-11 | C05E11.8a.1 | K02G10.4a.1 | FMRFamide-like peptide 12. | FMRFamide-like neuropeptides 11; FMRFamides and FMRFamide-like peptides are neuropeptides. [ASGGMRNALVRF-amide]: Acts as a ligand for the npr-22 receptor in vitro; Belongs to the FARP (FMRFamide related peptide) family. | 0.909 |
flp-12 | flp-19 | C05E11.8a.1 | M79.4.1 | FMRFamide-like peptide 12. | FMRFamide-like neuropeptides 19; FMRFamides and FMRFamide-like peptides are neuropeptides. WANQVRF-amide inhibits the activity of dissected pharyngeal myogenic muscle system; Belongs to the FARP (FMRFamide related peptide) family. | 0.871 |
flp-12 | flp-9 | C05E11.8a.1 | C36H8.3.1 | FMRFamide-like peptide 12. | FMRFamide-like neuropeptides 9; FMRFamides and FMRFamide-like peptides are neuropeptides. Belongs to the FARP (FMRFamide related peptide) family. | 0.860 |
flp-12 | pgal-1 | C05E11.8a.1 | F21F3.1.1 | FMRFamide-like peptide 12. | Probable peptidyl-alpha-hydroxyglycine alpha-amidating lyase pgal-1; Probable lyase that catalyzes an essential reaction in C- terminal alpha-amidation of peptides. Mediates the dismutation of the unstable peptidyl(2-hydroxyglycine) intermediate to glyoxylate and the corresponding desglycine peptide amide. C-terminal amidation of peptides such as neuropeptides is essential for full biological activity (By similarity). | 0.537 |
flp-12 | pghm-1 | C05E11.8a.1 | Y71G12B.4.1 | FMRFamide-like peptide 12. | Probable peptidylglycine alpha-hydroxylating monooxygenase 1; Monooxygenase that catalyzes an essential reaction in C- terminal alpha-amidation of peptides. Produces an unstable peptidyl(2- hydroxyglycine) intermediate. C-terminal amidation of peptides such as neuropeptides is essential for full biological activity. Belongs to the copper type II ascorbate-dependent monooxygenase family. | 0.447 |
flp-12 | sbt-1 | C05E11.8a.1 | T03D8.3.1 | FMRFamide-like peptide 12. | Seven B Two (Mammalian 7BT prohormone convertase chaperone) homolog. | 0.539 |
flp-12 | snet-1 | C05E11.8a.1 | C02F12.3.1 | FMRFamide-like peptide 12. | Protein snet-1; Negatively regulates chemotaxis and olfactory plasticity which is the change from positive chemotaxis to dispersal after prolonged exposure to an odorant. May be down-regulated in response to pheromone exposure, resulting in promotion of olfactory plasticity. | 0.448 |
flp-19 | flp-11 | M79.4.1 | K02G10.4a.1 | FMRFamide-like neuropeptides 19; FMRFamides and FMRFamide-like peptides are neuropeptides. WANQVRF-amide inhibits the activity of dissected pharyngeal myogenic muscle system; Belongs to the FARP (FMRFamide related peptide) family. | FMRFamide-like neuropeptides 11; FMRFamides and FMRFamide-like peptides are neuropeptides. [ASGGMRNALVRF-amide]: Acts as a ligand for the npr-22 receptor in vitro; Belongs to the FARP (FMRFamide related peptide) family. | 0.855 |
flp-19 | flp-12 | M79.4.1 | C05E11.8a.1 | FMRFamide-like neuropeptides 19; FMRFamides and FMRFamide-like peptides are neuropeptides. WANQVRF-amide inhibits the activity of dissected pharyngeal myogenic muscle system; Belongs to the FARP (FMRFamide related peptide) family. | FMRFamide-like peptide 12. | 0.871 |
flp-19 | flp-9 | M79.4.1 | C36H8.3.1 | FMRFamide-like neuropeptides 19; FMRFamides and FMRFamide-like peptides are neuropeptides. WANQVRF-amide inhibits the activity of dissected pharyngeal myogenic muscle system; Belongs to the FARP (FMRFamide related peptide) family. | FMRFamide-like neuropeptides 9; FMRFamides and FMRFamide-like peptides are neuropeptides. Belongs to the FARP (FMRFamide related peptide) family. | 0.791 |